The Efficacy and Safety of Radiotherapy Plus Niraparib and Toripalimab in Patients With Recurrent Small Cell Lung Cancer
Condition(s):Recurrent Small Cell Lung CancerLast Updated:May 2, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Recurrent Small Cell Lung CancerLast Updated:May 2, 2022Not yet recruiting
Condition(s):Recurrent Small Cell Lung CancerLast Updated:November 7, 2018Unknown status
Condition(s):Relapsed Small Cell Lung CancerLast Updated:March 15, 2024Recruiting
Condition(s):Recurrent Small Cell Lung CancerLast Updated:August 9, 2018Completed
Condition(s):Extensive Stage Small Cell Lung Cancer; Recurrent Small Cell Lung CancerLast Updated:June 26, 2020Terminated
Condition(s):Small Cell Lung CancerLast Updated:May 6, 2023Completed
Condition(s):Small-cell Lung Cancer; Relapsed Small Cell Lung Cancer; Recurrent Small Cell Lung CancerLast Updated:March 27, 2023Terminated
Condition(s):Extensive Stage Lung Small Cell Carcinoma; Limited Stage Lung Small Cell Carcinoma; Platinum-Resistant Lung Small Cell Carcinoma; Platinum-Sensitive Lung Small Cell Carcinoma; Recurrent Lung Small Cell CarcinomaLast Updated:March 26, 2024Recruiting
Condition(s):Lung CancerLast Updated:February 11, 2013Completed
Condition(s):Lung CancerLast Updated:July 7, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.